Publications by authors named "J E Vriezekolk"
Unlabelled: Following orthopaedic surgery, medication is vital for recovery and preventing complications, however drug-related problems (DRPs) can hinder medication use. The prevalence, types, and impact of DRPs on patients' activities of daily living (ADL) and the medication involved are unknown. Insight is needed for targeted interventions.
View Article and Find Full Text PDFObjectives: To investigate the support needs of patients with gout regarding information, communication, treatment and disease monitoring, and patients' views on and preferences for eHealth applications to address these needs.
Methods: A focus group study using purposive sampling was conducted. Three focus group sessions with a duration of 2 h per group were held with in total of 23 patients using urate-lowering therapy, recruited from primary and secondary care.
Determinants of Self-Management Behavior in Gout: A Scoping Review.
Arthritis Care Res (Hoboken)
October 2024
Objective: This study aimed to identify modifiable determinants of self-management behavior in patients with gout.
Methods: Four databases (Medline, Embase, PsycINFO, and CINAHL) were searched using terms related to gout, self-management, and determinants of behavior as described in the Theoretical Domains Framework (TDF). Two reviewers independently selected relevant studies via screening of title/abstract and full text.
Article Synopsis
- The study aimed to investigate how fatigue in patients with systemic sclerosis fluctuates day-to-day and its links to emotions, pain, and sleep quality.
- Conducted with 57 patients over 14 days, participants reported their levels of fatigue, negative and positive affect, pain, and sleep each day at set times.
- Results showed that increased negative affect, pain, and exertion led to more fatigue, while positive affect and better sleep reduced fatigue; integrating mood-boosting activities into fatigue management may be beneficial.
Objective: Long-term gout management is based on reducing serum urate by using urate-lowering therapy (ULT). A lifelong treat-to-target approach is advocated, although a ULT (taper to) stop attempt can be considered (treat-to-avoid symptoms approach) during remission. Exploring the beliefs of patients with gout on long-term ULT strategies during remission is important for optimizing gout management.
View Article and Find Full Text PDF